Clinical Trials Browser

Recruiting × Leuprolide × Head & Neck × Clear all

NCT06348264 2025-09-23

Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma

Phase 2 Recruiting

Salivary Gland Neoplasm Duct

NCT06145308 2025-09-15

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Phase 2 Recruiting

Salivary Gland Neoplasms